AzTrials
AzTrials

Functional FitnessNCT06199661

High-Intensity Exercise in Older Adults

A study testing APEX in people with Functional Fitness and Cognitive Abilities, run by University of California, Berkeley at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this interventional study was to test the high-intensity interval training called Aphasia Physical Exercise (APEX) in healthy older adults. The main questions it aimed to answer were: 1. what is the safety and feasibility of APEX? 2. what are APEX's acute physiological effects? 3. Read more about this study

Who is it for?
Ages 50 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Functional Fitness, Cognitive Abilities
What is being tested?
APEX
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited States
Study dates
6 Mar 2023to 1 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Between the ages of 50 and 80
  • Ambulatory and community-dwelling
  • Able to travel to University of San Francisco for weekly exercise classes
  • No serious underlying health or neurological conditions

Who cannot join

  • Inability to complete physical function assessment or inability to do a chair stand without using hands
  • Use of antidiabetic medications
  • Use of testosterone supplement or replacement
  • Clinical disorder precluding/interfering with participation or assessments (identified by Physical Activity Readiness Questionnaire (PAR-Q+)), including: unstable angina, arrhythmia, uncontrolled hypertension, end stage renal disease on hemodialysis, lower extremity amputation or paralysis, neurological conditions causing functional or pronounced cognitive impairments, active malignancy except for non-melanomatous skin cancers
  • Previous neurological history such as stroke, traumatic brain injury, multiple sclerosis, long-term pre-stroke seizures, Parkinson's, Alzheimer's, etc.
  • Unable to provide consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of San Francisco

    San Francisco, California, 94118

Other trials in United States

About this study

Official title: Feasibility and Efficacy of a High-Intensity Exercise Intervention in Elderly Healthy Controls

The goal of this interventional study was to test the high-intensity interval training called Aphasia Physical Exercise (APEX) in healthy older adults. The main questions it aimed to answer were:

  1. what is the safety and feasibility of APEX?
  2. what are APEX's acute physiological effects?
  3. what is APEX's effects on functional fitness?
  4. what is APEX's effects on cognition?
Read more

Participants underwent:

  • Baseline testing session (#1) with cognitive measures only (a week before the Pre-exercise session);
  • Pre-exercise session (#2) with maximum oxygen consumption and heart rate assessment, functional fitness and cognitive measures (3-7 days before the start of the exercise program);
  • APEX program, two APEX classes per week for four weeks (eight classes in total);
  • Post-exercise session (#3), functional fitness and cognitive measures, (0-2 days after the end of the exercise program).
Being tested
APEX

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • APEXBehavioural

    Also called Physical exercise intervention incorporating high-intensity interval training

    Three phases: warm-up, high-intensity interval training (HIIT) phase, cool-down. A 10-minute warm-up included deep breathing meditation and dynamic joint mobility exercises. Then, a 40-minute strength and balance workout in HIIT format with five different high-intensity (HI) exercises interspersed with five different postural stability recovery exercises. The HI intervals focused on enhancing cardiovascular fitness, muscle strength, and motor performance. The recovery intervals incorporated balance and mobility exercises. The HI exercises lasted 30 seconds for the first three weeks and then increased to 45 seconds in the fourth week while the recovery exercises lasted 60 seconds throughout the entire intervention. The HIIT phase was repeated three times in the 40 minute block. Lastly, a 10-minute cooldown consisting of standing and seated exercises similar to the warm-up.

Study groups in NCT06199661
Study groupRoleWhat they receive
APEXExperimentalPhysical exercise intervention based on high-intensity interval training
Receives: Behavioral: APEX

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attendance Rate

    The number of classes attended out of eight total classes.

    Measured: 4 weeks during intervention

  2. Heart Rate

    Heart rate measured in beats per minute.

    Measured: 4 weeks during intervention

  3. Functional Reach Test Distance

    The distance in inches of an individual's forward reach with one arm while maintaining a standing position with feet flat on the floor at hip width.

    Measured: Once 3-7 days before start of intervention and once 0-2 days after end of intervention

  4. Timed Up-And-Go Time

    The number of seconds for an individual to rise from a seated position, walk eight feet, turn around, and return to a seated position.

    Measured: Once 3-7 days before start of intervention and once 0-2 days after end of intervention

  5. Number of Steps in 2-minute Step Test

    The number of right knee raises completed in two minutes while marching in place and raising each knee to a point midway between the patella (kneecap) and iliac crest (top hip bone).

    Measured: Once 3-7 days before start of intervention and once 0-2 days after end of intervention

  6. Number of Repetitions in 30-Second Chair Stand Test

    The number of sit-to-stands completed in 30 seconds on a standard 17" seat-height chair with arms folded across the chest.

    Measured: Once 3-7 days before start of intervention and once 0-2 days after end of intervention

  7. Visual Search Task Accuracy

    Number of correct trials

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  8. Visual Search Task Reaction Time

    Reaction time on correct trials in seconds

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  9. Forward Digit Span

    The length of the longest sequence of random digits that a participant can correctly recall twice.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  10. Backward Digit Span

    The length of the longest sequence of random digits that a participant can correctly report backward twice.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  11. Forward Spatial Span

    The length of the longest sequence of random positions that a participant can correctly recall.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  12. Backward Spatial Span

    The length of the longest sequence of random positions that a participant can correctly report backward.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  13. Go/No-Go Task Hits

    Hits are the proportion of correct responses on trials when "go" is presented.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  14. Go/No-Go Task Reaction Times

    Reaction times are for hit trials only (correct responses when "go" is presented) in seconds.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  15. Flanker Task Accuracy

    Number of correct trials.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  16. Flanker Task Reaction Times

    Reaction time on correct trials in seconds.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  17. Stroop Task Accuracy

    Number of correct trials.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

  18. Stroop Task Reaction Times

    Reaction time on correct trials in seconds.

    Measured: Once 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2024
  2. Study start6 Mar 2023
  3. Primary completion1 Jun 2023
  4. Study completion1 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06199661
Sponsor's protocol ID
1884
Status last verified
Dec 2023
First submitted
13 Dec 2023
Last updated
10 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing APEX in people with Functional Fitness and Cognitive Abilities, run by University of California, Berkeley at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attendance Rate (time frame: 4 weeks during intervention). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in